Yi-Chen Chia

Title: Yi-Chen Chia: Innovator in Cancer and Diabetes Treatment

Introduction

Yi-Chen Chia is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the fields of cancer treatment and diabetes management. With a total of 2 patents, his work focuses on innovative formulations that enhance therapeutic efficacy.

Latest Patents

One of Yi-Chen Chia's latest patents is titled "HCD formulation for cancer treatment." This invention provides a novel formulation aimed at improving cancer treatment outcomes. It specifically involves copper-modified silica nanoparticles loaded with HCD, which demonstrate better efficacy compared to some conventional anticancer drugs. Another significant patent is "Method and composition for treating diabetes mellitus." This invention relates to a method for glycemic control in subjects with diabetes. It comprises administering a pharmaceutical composition that includes an aliphatic alcohol with a general formula of CH(CH)CHOH, where n is an integer from 10 to 40, such as tetracosanol, along with a pharmaceutically acceptable carrier.

Career Highlights

Yi-Chen Chia is affiliated with National Dong Hwa University, where he conducts research and develops innovative solutions in healthcare. His work has garnered attention for its potential impact on patient care and treatment methodologies.

Collaborations

Some of his notable coworkers include Ching-Feng Weng and Chia-Hung Lee, who contribute to the collaborative research environment at the university.

Conclusion

Yi-Chen Chia's innovative patents in cancer and diabetes treatment highlight his commitment to advancing medical science. His contributions are paving the way for more effective therapeutic options in these critical areas.